Clinical trialNCT01666951CompletedPhase 2Interventional

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

SponsorVeloxis PharmaceuticalsEnrollment36Renal Failure

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the pharmacokinetics of LCP-Tacro tablets administered once-daily compared to Prograf capsules administered twice-daily after kidney transplantation.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

William Polvino, MD
Veloxis Pharmaceuticals
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Clinical Investigative Site 000015
San Diego, California, United States
Clinical Investigative Site 000012
San Francisco, California, United States
Clinical Investigative Site 00004
Aurora, Colorado, United States
Clinical Investigative Site 000002
Tampa, Florida, United States
Clinical Investigative Site 000005
Lexington, Kentucky, United States
Clinical Investigative Site 000009
Ann Arbor, Michigan, United States
Clinical Investigative Site 000010
Livingston, New Jersey, United States
Clinical Investigative Site 000011
Buffalo, New York, United States
Clinical Investigative Site 00006
New York, New York, United States
Clinical Investigative Site 00008
Cleveland, Ohio, United States
Clinical Investigative Site 00003
Philadelphia, Pennsylvania, United States
Clinical Investigative Site 000013
Dallas, Texas, United States
Clinical Investigative Site 00001
Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

LCP-Tacro tabletsPrograf

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2012
Primary completion: 31 Mar 2013
Completion: 31 May 2013
Last update posted: 7 Jul 2015
Registered enrollment: 36
Registry id: NCT01666951

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.